X0306 4 2021-02-03 0 0001088856 CORCEPT THERAPEUTICS INC CORT 0001817838 Lyon Joseph Douglas C/O CORCEPT THERAPEUTICS INCORPORATED 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 0 1 0 0 Chief Accounting Officer Common Stock 2021-02-03 4 M 0 25000 8.27 A 25000 D Common Stock 2021-02-03 4 S 0 25000 29.1828 D 0 D Stock Option (Right to Buy) 8.27 2021-02-03 4 M 0 25000 0.00 D 2027-02-10 Common Stock 25000 29167 D These transactions were made pursuant to the terms of a 10b5-1 plan in effect at the time of sale of the shares. Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $28.86 to $29.71 per share. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request. Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of February 7, 2017, so that the total number of shares subject to this option becomes fully vested and exercisable on February 7, 2021. /s/ G. Charles Robb, Attorney-in-Fact for Joseph Douglas Lyon 2021-02-04